AI and early digital twin models can help forecast trial performance, refine site feasibility, and anticipate operational needs before enrollment begins.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
ON-DEMAND WEBINARS
PMCF costs are straining device budgets. Discover how AI-assisted review and real-world data from other regions can help you meet EU requirements more efficiently.
Looking to minimize time on outreach or accelerate patient recruitment? Uncover how this partnership was able to deliver positive overall results for sponsors, ultimately benefiting patients.
Explore the forefront of wearable digital health technology and its potential impact on advancing clinical research and healthcare innovation.
Tune in as Castor’s Director of Solutions Consulting Kristen Harnack illustrates how a modular approach to clinical technology can help you conduct an RWE study.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![The US Biosimilar Approval Pathway: Policy Precedes Science - A Regulatory Perspective]( "Why Legacy RTSM Systems Create Risk in Biosimilar Trials")
Why Legacy RTSM Systems Create Risk in Biosimilar TrialsLearn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
-
![gettyimages-1154110666 decentralized trials]( "You Don't Have To Digitize Everything, You Just Have To Start")
You Don't Have To Digitize Everything, You Just Have To StartFeeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.
-
![Women Talking On Phone Working From Home]( "How A Remote ePRO Solution Helped Reduce Patient Burden")
How A Remote ePRO Solution Helped Reduce Patient BurdenDiscover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.
-
![GettyImages-1257716223 fda guide]( "Key Takeaways From The Recent FDA DCT Draft Guidance")
Key Takeaways From The Recent FDA DCT Draft GuidanceGet an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.
-
![GettyImages-1292777576 doctor computer]( "Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial")
Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical TrialEmbrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.
-
![JavaScript Breaks Data Out From Bar(codes)]( "Real-World Data Capture With EDC")
Real-World Data Capture With EDCThis case study explores how a Ph.D. candidate partnered with Castor to develop software that seamlessly moves RWD between hospital systems and Castor’s EDC.
-
![video conference team meeting-GettyImages-2095813137]( "The Strategic Role Of KOLs In Rare Disease Drug Development")
The Strategic Role Of KOLs In Rare Disease Drug DevelopmentEngaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.
-
![GettyImages-1311977468 site payments]( "Enhancing Participant Payments: A New Approach")
Enhancing Participant Payments: A New ApproachManaging participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
![Doctor Using Digital Tablet GettyImages-1530254515]( "eCOA Evolution: Have We Overcomplicated It?")
eCOA Evolution: Have We Overcomplicated It?eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity.
-
![375_250-clinical_paper_coas_GettyImages-1483251775]( "Paper COAs In 2026? It's Not \"Cheaper,\" It's Riskier")
Paper COAs In 2026? It's Not "Cheaper," It's RiskierPaper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
